Pharmacokinetic characteristics of cilostazol 200 mg controlled-release tablet compared with two cilostazol 100 mg immediate-release tablets (Pletal) after single oral dose in healthy Korean male volunteers | Zendy

Jin Dong Son | Zendy; Sang Min Cho | Zendy; Youn Woong Choi | Zendy; Soo-Hwan Kim | Zendy; In Sun Kwon | Zendy; EunHeui Jin | Zendy; Jae Woo Kim | Zendy; Jang Hee Hong | Zendy

Open Access

Pharmacokinetic characteristics of cilostazol 200 mg controlled-release tablet compared with two cilostazol 100 mg immediate-release tablets (Pletal) after single oral dose in healthy Korean male volunteers

Author(s) -

Jin Dong Son,

Sang Min Cho,

Youn Woong Choi,

Soo-Hwan Kim,

In Sun Kwon,

EunHeui Jin,

Jae Woo Kim,

Jang Hee Hong

Publication year - 2016

Publication title -

translational and clinical pharmacology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.166

H-Index - 6

eISSN - 2383-5427

pISSN - 2289-0882

DOI - 10.12793/tcp.2016.24.4.183

Subject(s) - cilostazol , immediate release , medicine , pharmacokinetics , pharmacology , aspirin

Pharmacokinetic characteristics of cilostazol 200 mg controlled-release tablet compared with two cilostazol 100 mg immediate-release tablets (Pletal) after single oral dose in healthy Korean male volunteers Jin Dong Son, Sang Min Cho, Youn Woong Choi, Soo-Hwan Kim, In Sun Kwon, Eun-Heui Jin, Jae Woo Kim and Jang Hee Hong* Department of Medical Science, College of Medicine, Chungnam National University, Daejeon 35015, republic of Korea, Korea United Pharm.Inc., Seoul 06116, Republic of Korea, Caleb Multilab Inc., Seoul 06745, Republic of Korea, Clinical Trials Center, Chungnam National University Hospital, Daejeon 35015, South Korea, Department of Pharmacology, College of Medicine, Chungnam National University, Daejeon 35015, Republic of Korea *Correspondence: J.H. Hong; Tel: +82-42-280-6940, Fax: +82-42-280-6940, E-mail: boniii@cnu.ac.kr

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research